Good morning!

CVS (LON:CVSG)

As far as I'm aware this is the only UK listed (let's see if I can spell it right this time!) veterinary chain. I last looked at it on publication of interims to 31 Dec 2013 here, and at 306p per share was wavering between thinking it was priced about right to a little too highly. The price now is a little higher, at 324p, giving a mkt cap of £187.7m.

There's no denying it's a good growth business, operating in an area where people are spending more on their pets - e.g. having operations done on animals, instead of 20+ years ago the norm was to put them down if anything serious went wrong with a pet's health. So it's all down to whether the valuation is reasonable.

The other issue is their Balance Sheet, which is horrible. When I last looked it had negative tangible assets of £30.8m, funded by £32.1m of net debt. The issue being that debt has to be repaid at some point, which is money that would otherwise be available for dividends, plus it has an ongoing (and likely to increase) servicing cost in interest payments and arrangement fees. Bear in mind that whilst interest rates may be low, a lot of banks are coining it in with excessive arrangements fees, a hidden cost. So debt is not as cheap as it might look at first. The other issue with debt is that it makes an investment much more high risk - if something serious goes wrong with trading, a highly indebted company immediately has its back against the wall, may breach banking covenants, and end up either going bust or having to do an emergency fundraising at the worst possible time & price, leading to heavy dilution. These are the reasons why I try to avoid highly indebted companies.

This morning's trading update sounds good. The key sentence says;

The Group will announce its full year results on Friday 19 September 2014 and these are expected to be in line with market expectations.

Jolly good. Lots more detail is given, but I'm not interested in that. All that matters now is the outlook statement. This is woolly, but positive-sounding;

The Board is encouraged by the recent improvement in like-for-like sales performance, the continuing potential for further acquisitions and the general progress in all divisions of the…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here